Your browser doesn't support javascript.
loading
Reducing the hidden burden of severe asthma: recognition and referrals from primary practice.
Humbert, Marc; Bourdin, Arnaud; Papadopoulos, Nikolaos G; Holgate, Stephen T; Hanania, Nicola A; Halpin, David M G; Chapman, Kenneth R; Gavornikova, Marcela; Price, David B; Kaplan, Alan; Heaney, Liam G.
Afiliação
  • Humbert M; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicetre, France.
  • Bourdin A; Service de Pneumologie, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
  • Papadopoulos NG; Department of Respiratory Diseases, Université de Montpellier, PhyMedExp, INSERM, CNRS, CHU de Montpellier, Montpellier, France.
  • Holgate ST; Division of Infection, Inflammation & Respiratory Medicine, The University of Manchester, Manchester, UK.
  • Hanania NA; The Allergy Department, National & Kapodistrian University of Athens, Athens, Greece.
  • Halpin DMG; Faculty of Medicine, University of Southampton, Southampton, UK.
  • Chapman KR; Section of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Gavornikova M; Royal Devon & Exeter Hospital, Exeter, UK.
  • Price DB; Asthma and Airway Centre, University Health Network, and University of Toronto, Toronto, Ontario, Canada.
  • Kaplan A; Novartis Pharma AG, Basel, Switzerland.
  • Heaney LG; Observational and Pragmatic Research Institute, Singapore.
J Asthma ; 58(7): 849-854, 2021 07.
Article em En | MEDLINE | ID: mdl-32347748
ABSTRACT
Since their introduction many decades ago, systemic corticosteroids have become a mainstay treatment for asthma. Despite being a highly effective therapy, corticosteroids can cause significant adverse effects in patients. This results in a "double hit" for some patients as they suffer the burden of disease as well as the burden of treatment-induced morbidity.This article aims to raise awareness of the potential, harmful side effects of prolonged or repeated exposure to systemic corticosteroids in asthma. It also highlights the importance of referral of the appropriate patients with asthma from primary care for specialist assessment once other considerations such as adherence, inhaler technique and co-morbidity have been evaluated. We propose a simple decision step that may help busy primary care physicians and general practitioners to identify patients who could benefit from specialist assessment.Our decision step suggests that a patient with asthma should be reviewed at least once by an asthma specialist if he/she (i) has received ≥2 courses of oral corticosteroids in the previous year; asthma remains uncontrolled despite good adherence and inhaler technique; or (ii) has attended an emergency department or was hospitalized for asthma care.Such referral could facilitate wider access to diagnostic tools, in-depth assessment of confounding comorbidities, and non-corticosteroid-based therapies as needed, which may be unavailable in primary practice.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atenção Primária à Saúde / Encaminhamento e Consulta / Asma / Corticosteroides Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Asthma Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atenção Primária à Saúde / Encaminhamento e Consulta / Asma / Corticosteroides Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Asthma Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França